116 related articles for article (PubMed ID: 22449656)
1. Risk assessment and prevention of contrast-induced nephropathy in patients undergoing coronary angiography.
Okumura K; Sone T
Intern Med; 2012; 51(6):519-21. PubMed ID: 22449656
[No Abstract] [Full Text] [Related]
2. Prevention of contrast-induced nephropathy with ascorbic acid.
Zhou L; Chen H
Intern Med; 2012; 51(6):531-5. PubMed ID: 22449658
[TBL] [Abstract][Full Text] [Related]
3. Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention.
Spargias K; Alexopoulos E; Kyrzopoulos S; Iokovis P; Greenwood DC; Manginas A; Voudris V; Pavlides G; Buller CE; Kremastinos D; Cokkinos DV
Circulation; 2004 Nov; 110(18):2837-42. PubMed ID: 15492300
[TBL] [Abstract][Full Text] [Related]
4. Ascorbic acid for the prevention of contrast-induced acute kidney injury.
McCullough PA; Akrawinthawong K
J Am Coll Cardiol; 2013 Dec; 62(23):2176-7. PubMed ID: 23994411
[No Abstract] [Full Text] [Related]
5. Ascorbic Acid for the prevention of contrast-induced nephropathy after coronary angiography in patients with chronic renal impairment: a randomized controlled trial.
Dvoršak B; Kanič V; Ekart R; Bevc S; Hojs R
Ther Apher Dial; 2013 Aug; 17(4):384-90. PubMed ID: 23931876
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of ascorbic acid, N-acetylcysteine, or combination of both on top of saline hydration versus saline hydration alone on prevention of contrast-Induced nephropathy: a prospective randomized study.
Albabtain MA; Almasood A; Alshurafah H; Alamri H; Tamim H
J Interv Cardiol; 2013 Feb; 26(1):90-6. PubMed ID: 22994682
[TBL] [Abstract][Full Text] [Related]
7. Prevention of Contrast-Induced Acute Kidney Injury: an Update.
Chalikias G; Drosos I; Tziakas DN
Cardiovasc Drugs Ther; 2016 Oct; 30(5):515-524. PubMed ID: 27541275
[TBL] [Abstract][Full Text] [Related]
8. N-acetylcysteine versus AScorbic acid for preventing contrast-Induced nephropathy in patients with renal insufficiency undergoing coronary angiography NASPI study-a prospective randomized controlled trial.
Jo SH; Koo BK; Park JS; Kang HJ; Kim YJ; Kim HL; Chae IH; Choi DJ; Sohn DW; Oh BH; Park YB; Choi YS; Kim HS
Am Heart J; 2009 Mar; 157(3):576-83. PubMed ID: 19249432
[TBL] [Abstract][Full Text] [Related]
9. Does ascorbic acid protect against contrast-induced acute kidney injury in patients undergoing coronary angiography: a systematic review with meta-analysis of randomized, controlled trials.
Sadat U; Usman A; Gillard JH; Boyle JR
J Am Coll Cardiol; 2013 Dec; 62(23):2167-75. PubMed ID: 23994417
[TBL] [Abstract][Full Text] [Related]
10. The use of bilirubin for the prevention of contrast-induced nephropathy.
Halacli B; Ecder T
Med Hypotheses; 2009 Feb; 72(2):232-3. PubMed ID: 18945551
[No Abstract] [Full Text] [Related]
11. N-acetylcysteine versus ascorbic acid or N-acetylcysteine plus ascorbic acid in preventing contrast-induced nephropathy: A meta-analysis.
Feng Y; Huang X; Li L; Chen Z
Nephrology (Carlton); 2018 Jun; 23(6):530-538. PubMed ID: 28452187
[TBL] [Abstract][Full Text] [Related]
12. Cardiology Grand Rounds from The University of North Carolina at Chapel Hill. Contrast induced nephropathy after angiography.
Agrawal M; Stouffer GA
Am J Med Sci; 2002 May; 323(5):252-8. PubMed ID: 12018667
[No Abstract] [Full Text] [Related]
13. Usefulness of N-acetylcysteine or ascorbic acid versus placebo to prevent contrast-induced acute kidney injury in patients undergoing elective cardiac catheterization: a single-center, prospective, randomized, double-blind, placebo-controlled trial.
Brueck M; Cengiz H; Hoeltgen R; Wieczorek M; Boedeker RH; Scheibelhut C; Boening A
J Invasive Cardiol; 2013 Jun; 25(6):276-83. PubMed ID: 23735352
[TBL] [Abstract][Full Text] [Related]
14. Coenzyme Q10 combined with trimetazidine in the prevention of contrast-induced nephropathy in patients with coronary heart disease complicated with renal dysfunction undergoing elective cardiac catheterization: a randomized control study and in vivo study.
Chen F; Liu F; Lu J; Yang X; Xiao B; Jin Y; Zhang J
Eur J Med Res; 2018 May; 23(1):23. PubMed ID: 29776437
[TBL] [Abstract][Full Text] [Related]
15. Reduced Glutathione for Prevention of Renal Outcomes in Patients Undergoing Selective Coronary Angiography or Intervention.
Wang C; Wang W; Ma S; Lu J; Shi H; Ding F
J Interv Cardiol; 2015 Jun; 28(3):249-56. PubMed ID: 25989827
[TBL] [Abstract][Full Text] [Related]
16. Prevention of radiocontrast induced acute renal failure with mannitol.
Old CW; Lehrner LM
Lancet; 1980 Apr; 1(8173):885. PubMed ID: 6103250
[No Abstract] [Full Text] [Related]
17. [Contrast nephropathy in cardiac procedures: no advantages with prophylactic use of N-acetylcysteine (NAC)].
Vallero A; Cesano G; Pozzato M; Garbo R; Minelli M; Quarello F; Formica M
G Ital Nefrol; 2002; 19(5):529-33. PubMed ID: 12439841
[TBL] [Abstract][Full Text] [Related]
18. Impact of Rosuvastatin on contrast-induced acute kidney injury in patients at high risk for nephropathy undergoing elective angiography.
Abaci O; Arat Ozkan A; Kocas C; Cetinkal G; Sukru Karaca O; Baydar O; Kaya A; Gurmen T
Am J Cardiol; 2015 Apr; 115(7):867-71. PubMed ID: 25670636
[TBL] [Abstract][Full Text] [Related]
19. Contrast-induced nephropathy.
Wong GT; Irwin MG
Br J Anaesth; 2007 Oct; 99(4):474-83. PubMed ID: 17681968
[TBL] [Abstract][Full Text] [Related]
20. Preventing the unpreventable? Rotational angiography for the prevention of contrast-induced nephropathy.
Menon D; Gruberg L
J Invasive Cardiol; 2010 Sep; 22(9):432-3. PubMed ID: 20814051
[No Abstract] [Full Text] [Related]
[Next] [New Search]
